JavaScript is required to consult this page
Press release17 Oct 2022

EBRAINS welcomes Central Institute of Mental Health as new associate member

Central Institute of Mental Health Logo

The membership went into effect on 1 May 2022. It will give CIMH the opportunity to co-design future iterations of EBRAINS’ cutting-edge tools and services. These state-of-the-art capabilities – which cover data sharing, atlasing, modelling, simulation, high-performance computing, and neurorobotics – aim to help European researchers to address major challenges in brain health, benefiting from insights into data science, brain organization, and artificial intelligence gathered from the EU Flagship Human Brain Project.

The Central Institute of Mental Health (CIMH) stands for internationally outstanding research and pioneering treatment concepts in psychiatry and psychotherapy, child and adolescent psychiatry, psychosomatics and addiction medicine. The CIMH clinics provide psychiatric care for the population of Mannheim. At the CIMH, mentally ill people of all ages can rely on the most advanced treatments based on international standards of knowledge. Educating people about mental illness, creating understanding for those affected and strengthening prevention is another important part of our work. In psychiatric research, the CIMH is one of the leading institutions in Europe. Since 2021, it has been a site of the German Centre for Mental Health. The CIMH is institutionally linked to the University of Heidelberg through jointly appointed professors from the Mannheim Medical Faculty.

“Progress in translation for mental disorders critically depends on an in depth understanding of brain function and its alterations. Here, we look forward to contribute large-scale imaging databases, modeling and analysis expertise to EBRAINS. This impact will be scaled up through in-depth collaboration with our partner institutions in the DZPG”

Prof. Dr. Andreas Meyer-Lindenberg
Head of the Executive Board of CIMH and Medical Director of the Clinic of Psychiatry and Psychotherapy at CIMH

“CIMH brings with it world-class expertise in psychiatry and psychotherapy but also cognitive and clinical neuroscience. It combines active clinical inpatient and outpatient programmes and has pioneered a number of approaches, including the imaging of fMRI-endophenotypes in humans with risk genes for psychiatric disorders. I am convinced that the CIMH will be a greatly valuable member of EBRAINS.”

Paweł Świeboda
CEO of EBRAINS

About EBRAINS

EBRAINS is a new digital research infrastructure (RI), created by the EU-funded Human Brain Project (HBP), to foster brain-related research and to help translate the latest scientific discoveries into innovation in medicine and industry, for the benefit of patients and society.

It draws on cutting-edge neuroscience and offers an extensive range of brain data sets, atlasesmodelling and simulation tools, easy access to high-performance computing resources and to robotics and neuromorphic platforms.

All academic researchers have open access to EBRAINS’ state-of-the art services. Industry researchers are also very welcome to use the platform under specific agreements. For more information about EBRAINS, please contact us at info@ebrains.eu or visit https://ebrains.eu/

ESFRI Logo

EBRAINS is listed on the ESFRI roadmap

About the Human Brain Project

The Human Brain Project (HBP) is the largest brain science project in Europe and stands among the biggest research projects ever funded by the European Union. It is one of the three FET Flagship Projects of the EU. At the interface of neuroscience and information technology, the HBP investigates the brain and its diseases with the help of highly advanced methods from computing, neuroinformatics and artificial intelligence and drives innovation in fields like brain-inspired computing and neurorobotics.

Media Contact
Pedro Teixeira
Tel.: +32 499 90 70 44
pedro.teixeira@ebrains.eu

News & events

All news & events

Make the most out of EBRAINS

EBRAINS is open and free. Sign up now for complete access to our tools and services.

Ready to get started?Create your account